Form 4 for ACRS Aclaris Therapeutics, Inc.
Accepted 2023-03-09 00:00:00 ET · period of report 2023-03-09 · accession 0001209191-23-017626 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-09 | 2023-03-09 | ACRS | Manion Douglas J. | Pres, CEO, Dir | P - Purchase | $7.74 | +6,500 | 6,500 | New | +$50.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-09 | P | A | 6,500 | $7.74 | 6,500 | D | — | — |